Lucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Beats Revenue Estimates

Lucid Diagnostics Inc. (LUCD) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.19 per share a year ago.